$rNVO
Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
$259.43K
▲+7.16%from 30d ago
$47.51
▲+7.29%from 30d ago
0
$345.53
Novo Nordisk A/S Bitget Metrics
Metric
Show % of Total
Key Facts
Name
Novo Nordisk A/S Bitget
Ticker
rNVO
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$259,426
▲
NAV
$47.51
▲
Price
—
Token Supply
5,460.46
▲
Circulating Supply
5,460.46
▲
7D APY
—
30D APY
—
Holders
—
Trailing 30D Active Addresses
2
△
Monthly Transfer Count
38
▲
Monthly Transfer Volume
$346
△
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDTUSDC
Subscription Time
Instant
Min. Investment
20 USDT
Subscription Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDT
Redemption Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0.10%
Subscription Fees
0.10%
RWA.xyzAll Rights Reserved